151 related articles for article (PubMed ID: 3349922)
1. Absorption of intraperitoneal antibiotics.
Morse GD; Apicella MA; Walshe JJ
Drug Intell Clin Pharm; 1988 Jan; 22(1):58-61. PubMed ID: 3349922
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin disposition following intraperitoneal administration in children receiving peritoneal dialysis.
Blowey DL; Warady BA; Abdel-Rahman S; Frye RF; Manley HJ
Perit Dial Int; 2007; 27(1):79-85. PubMed ID: 17179516
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of clindamycin in the plasma and dialysate after intraperitoneal administration of clindamycin phosphoester to patients on continuous ambulatory peritoneal dialysis: an open-label, prospective, single-dose, two-institution study.
Chang MJ; Namgung H; Choi HD; Song YR; Kim SG; Oh JM; Shin WG
Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):504-9. PubMed ID: 22151828
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of once daily intra-peritoneal aztreonam and vancomycin in the treatment of CAPD peritonitis.
Brown J; Altmann P; Cunningham J; Shaw E; Marsh F
J Antimicrob Chemother; 1990 Jan; 25(1):141-7. PubMed ID: 2318749
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis.
Harford AM; Sica DA; Tartaglione T; Polk RE; Dalton HP; Poynor W
Nephron; 1986; 43(3):217-22. PubMed ID: 3724930
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal cefazolin and ceftazidime during short-dwell exchange in peritoneal dialysis patients with peritonitis.
Triyawatanyu P; Chariyavilaskul P; Phaisal W; Peerapornratana S; Kanjanabuch T; Praditpornsilpa K; Katavetin P
Perit Dial Int; 2020 Mar; 40(2):179-184. PubMed ID: 32063189
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peritonitis in continuous ambulatory peritoneal dialysis patients.
Tosukhowong T; Eiam-Ong S; Thamutok K; Wittayalertpanya S; Na Ayudhya DP
Perit Dial Int; 2001; 21(6):587-94. PubMed ID: 11783768
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of single daily intraperitoneal administration of aztreonam and cefuroxime in the treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD).
Fuiano G; Sepe V; Viscione M; Nani E; Conte G
Perit Dial Int; 1989; 9(4):273-5. PubMed ID: 2488380
[TBL] [Abstract][Full Text] [Related]
9. Once weekly intraperitoneal therapy for gram-positive peritonitis.
Morse GD; Nairn DK; Walshe JJ
Am J Kidney Dis; 1987 Oct; 10(4):300-5. PubMed ID: 3661551
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis in patients with peritonitis.
Montañés Pauls B; Almiñana MA; Casabó Alós VG
Eur J Pharm Sci; 2011 Jul; 43(4):212-6. PubMed ID: 21540106
[TBL] [Abstract][Full Text] [Related]
11. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
[TBL] [Abstract][Full Text] [Related]
12. Initial intraperitoneal therapy for CAPD peritonitis: the Network 9 Peritonitis Study.
Brier ME; Aronoff GR
Adv Perit Dial; 1994; 10():141-3. PubMed ID: 7999812
[TBL] [Abstract][Full Text] [Related]
13. Treatment of gram-positive peritonitis with two intraperitoneal doses of vancomycin in continuous ambulatory peritoneal dialysis patients.
Bastani B; Freer K; Read D; Bailey S; Sherman RA; Davis M; Engels D; Westervelt FB
Nephron; 1987; 45(4):283-5. PubMed ID: 3587467
[TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal (IP) vancomycin therapy for CAPD peritonitis--a prospective, randomized comparison of intermittent v continuous therapy.
Boyce NW; Wood C; Thomson NM; Kerr P; Atkins RC
Am J Kidney Dis; 1988 Oct; 12(4):304-6. PubMed ID: 3177373
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.
Kobayashi K; Nakamoto H; Okada S; Hoshitani K; Uchida K; Arima H; Shoda J; Takane Y; Ikeda N; Sugahara S; Okada H; Suzuki H
Adv Perit Dial; 2006; 22():65-8. PubMed ID: 16983942
[TBL] [Abstract][Full Text] [Related]
16. Intravenous or intraperitoneal vancomycin for the treatment of continuous ambulatory peritoneal dialysis associated gram-positive peritonitis?
Bailie GR; Morton R; Ganguli L; Keaney M; Waldek S
Nephron; 1987; 46(3):316-8. PubMed ID: 3627326
[TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal teicoplanin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis.
Bowley JA; Pickering SJ; Scantlebury AJ; Ackrill P; Jones DM
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():133-9. PubMed ID: 2965125
[TBL] [Abstract][Full Text] [Related]
18. [A rare cause of peritoneal dialysis-related peritonitis: Haemophilus influenzae].
Unal A; Perçin DE; Sipahioğlu MH; Kavuncuoğlu F; Tokgöz B; Oymak O; Utaş C
Mikrobiyol Bul; 2009 Jul; 43(3):477-80. PubMed ID: 19795624
[TBL] [Abstract][Full Text] [Related]
19. [Peritoneal dialysis-related eosinophilic peritonitis: a case report and literature review].
Tsai SM; Yan Y; Zhao HP; Wu B; Zuo L; Wang M
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 50(4):747-751. PubMed ID: 30122784
[TBL] [Abstract][Full Text] [Related]
20. Systemic absorption of intraperitoneal antimicrobials in continuous ambulatory peritoneal dialysis.
O'Brien MA; Mason NA
Clin Pharm; 1992 Mar; 11(3):246-54. PubMed ID: 1611814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
